Skip to main content
Go to the U of M home page
  • One Stop
  • MyU
Menu
  • About Us
    • About the Consortium
    • Staff/Contact Us
    • Leadership
    • History of the Consortium
    • Annual Reports
    • Consortium Policies
    • Land Acknowledgment
  • Members
  • News & Events
    • Events
    • News
    • Consortium Update (newsletter)
  • Grants & Research
    • About Grants & Research
    • Genomics & Precision Medicine
    • Bioengineering
    • Nanotechnology
    • Stem Cell
    • Neuroscience
    • End of Life
    • Other Grants
    • Consortium Research Awards
  • Publications
  • Resources
    • COVID-19 Resources
    • Highly Portable and Cloud-Enabled Neuroimaging Research
    • LawSeqSM Database

Breadcrumb

  1. Home
  2. Publications
  3. Nanodiagnostics and Nanotherapeutics: Building Research Ethics & Oversight

Nanodiagnostics and Nanotherapeutics: Building Research Ethics & Oversight

jlme
Published In
Journal of Law, Medicine & Ethics
Guest Editors
Jeffrey McCullough
Jeffrey P. Kahn
Cortney Jones
Issue
Winter, 2012
Issue Number
4
Volume
40
Related Grant
Nanodiagnostics and Nanotherapeutics: Building Research Ethics and Oversight

Symposium Articles

Introduction: The Challenge of Nanomedicine Human Subjects Research: Protecting Participants, Workers, Bystanders, and the Environment
An Empirical Examination of the Current State of Publically Available Nanotechnology Guidance Materials
A Portrait of Nanomedicine and Its Bioethical Implications
What is Unique About Nanomedicine: The Significance of the Mesoscale
Toward Correlation in In Vivo and In Vitro Nanotoxicology Studies
Building an Ethical Foundation for First-in-Human Nanotrials
Concepts of Risk in Nanomedicine Research
Nanomedicine First-in-Human Research: Challenges for Informed Consent
Prudent Precaution in Clinical Trials of Nanomedicines
Beyond Human Subjects: Risk, Ethics, and Clinical Development of Nanomedicines
Responsible Conduct in Nanomedicine Research: Environmental Concerns Beyond the Common Rule
Handling Worker and Third-Party Exposures to Nanotherapeutics During the Clinical Trails
Recommendations for Nanomedicine Human Subjects Research Oversight: An Evolutionary Approach for an Emerging Field

CONTACT US

316 Johnston Hall
101 Pleasant St. SE
Minneapolis, MN 55455

612-625-0055 office
612-624-9143 fax
consortm@umn.edu

Research & Innovation Office (RIO)
University-wide Centers

FOLLOW US

  Sign Up for our emails

                         

For Students, Faculty, and Staff

  • One Stop
  • MyU
  • About Us
    • About the Consortium
    • Staff/Contact Us
    • Leadership
    • History of the Consortium
    • Annual Reports
    • Consortium Policies
    • Land Acknowledgment
  • Members
  • News & Events
    • Events
    • News
    • Consortium Update (newsletter)
  • Grants & Research
    • About Grants & Research
    • Genomics & Precision Medicine
    • Bioengineering
    • Nanotechnology
    • Stem Cell
    • Neuroscience
    • End of Life
    • Other Grants
    • Consortium Research Awards
  • Publications
  • Resources
    • COVID-19 Resources
    • Highly Portable and Cloud-Enabled Neuroimaging Research
    • LawSeqSM Database